Daily Oncology News
Drug is now sanctioned for people who have received at least two prior standard therapies.
Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.
Study shows biggest improvements in post-cancer survival for people diagnosed between ages 50 and 64.
Risks and benefits of routine mammography continue to be debated, but educating women about the possibility of overdiagnosis from mammography screening may make some of them less likely to get the test.
Company-funded research followed nearly 7,500 children over 10 years, but established no increased cancer risk caused by the use of pimecrolimus (Elidel) cream to treat eczema in children.
Oncology care teams should provide more guidance on lifestyle change as part of survivorship care, according to recent research.
Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.
From 2004 to 2009, marked increase in observation among men with low-risk prostate cancer has been observed.
Guideline outlines recommended follow-up care for prostate cancer survivors
Patients who participate in their medical decisions have a better impression about their level of care, a new study suggests, but researchers still unclear as to whether shared decision-making results in better outcomes.
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- Radiation therapy used most often for prostate cancer regardless of decision-making factors
- Precise risk assessment for gastric and breast cancers among CDH1 gene mutation carriers may improve genetic counseling
- Farydak (panobinostat) now FDA-approved for multiple myeloma
- ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer
- Urine test could help to guide treatment of bladder cancer
- Multiple studies are exploring whether e-cigarettes help smokers quit or continue smoking
- Study identifies reasons for ibrutinib discontinuation in patients with chronic lymphocytic leukemia
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|